Table 1 Patient characteristics.
Characteristics | GVHD (n = 12) | Non-GVHD (n = 10) | P Value |
|---|---|---|---|
Age, y | 52.16 ± 12.55 | 47.30 ± 18.55 | 0.473 |
Gender, no. (male/female) | 5/7 | 5/5 | 1.000 |
Time-period after HSCT, m | 84.58 ± 65.13 | 72.60 ± 59.59 | 0.660 |
Type of HSCT, no. (BMT/PBSCT/CBT) | 8/4/0 | 5/1/4 | Â |
Type of donor, no. (related/unrelated) | 5/7 | 5/5 | 1.000 |
Primary disease (no.) | |||
| Â | AML (4) | AML (3) | Â |
| Â | MDS (4) | HL (1) | Â |
| Â | ALL (2) | ALL (2) | Â |
| Â | CML (1) | CML (1) | Â |
| Â | PTCL (1) | CMML (1) | Â |
| Â | Â | AA (1) | Â |
| Â | Â | NHL (1) | Â |
TBI, no. (yes/no) | 8/4 | 10/0 | 0.096 |
Duration of DED, m | 67.00 ± 61.74 | — |  |
SIT, no. (yes/no) | 7/5 | 2/8 | 0.099 |
